Early diagnosis of pancreatic cancer using immune system clues
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is looking for a new way to catch pancreatic cancer early by checking your immune system's signals. It compares people with pancreatic cancer, people with non-cancerous pancreatic growths, and healthy volunteers to find a simple blood test that could help diagnose the disease sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with pancreatic cancer, have a benign pancreatic lesion, or are a healthy volunteer.
- You can sign a consent form to participate.
- You have not had any other cancer before.
- Your major organs (like heart, liver, kidneys) are working normally.
- You do not have a severely weakened immune system, active tuberculosis, or HIV.
- You are willing to come back for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new blood test that looks for cancer-specific immune cells after surgery for pancreatic cancer. It aims to see if the test can detect any remaining cancer cells earlier than standard methods, which could help guide further treatment decisions.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study builds an immune map of how pancreatic cancer changes over time. It may help doctors better understand the disease and find new treatment strategies.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.